Research on sampling of COVID-19 with lidocaine-soaked swab.

Medicine (Baltimore)

Experiment Center, Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: This study explores the comfort level of lidocaine-soaked swab for nucleic acid detection of COVID-19 (Coronavirus Disease 2019) patients. Oropharyngeal and nasopharyngeal secretions from COVID-19 patients were collected using lidocaine-soaked swabs.

Methods: COVID-19 patients were randomly divided into experimental group and control group, with 25 patients in each group. The first oropharyngeal and nasopharyngeal swabs (experimental group) was be soaked in lidocaine hydrochloride injection. The control group was tested for novel coronavirus nucleic acid by routine nasopharyngeal/oropharyngeal swabs. Then, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) was detected in 2 groups by real-time reverse transcription-polymerase chain reaction (RT-PCR). Participants' discomfort was assessed by a visual analog scale. Then, the discomfort and cycle threshold (Ct) values after sampling were compared between the 2 groups.

Results: A total of 50 patients were enrolled in the study. There were no lidocaine-related complications during sampling. COVID-19 inpatients feel more comfortable with the use of lidocaine-soaked swabs (nasopharyngeal 3.44 ± 1.42 vs 5.68 ± 0.95, P < .01; oropharyngeal 4.4 ± 1.53 vs 8.92 ± 0.91, P < .01). Ct values of nasopharyngeal swab specimens were generally lower than those of oropharyngeal swab specimens. There was no statistically significant difference between Ct value results of the 2 groups. The use of lidocaine-soaked swabs for sampling of COVID-19 reduces patients' discomfort. This method is worth popularizing in novel coronavirus sampling.

Conclusion: The use of lidocaine-soaked swabs for sampling of COVID-19 reduces patients' discomfort, which it has no obvious effect on Ct value. This method is worth popularizing in novel coronavirus sampling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366947PMC
http://dx.doi.org/10.1097/MD.0000000000043918DOI Listing

Publication Analysis

Top Keywords

sampling covid-19
8
lidocaine-soaked swab
8
nucleic acid
8
oropharyngeal nasopharyngeal
8
covid-19 patients
8
experimental group
8
control group
8
patients
5
group
5
lidocaine-soaked
4

Similar Publications

Community Resident Survey of COVID-19 Vaccine Attitude, Knowledge and Acceptance.

J Healthc Sci Humanit

January 2024

Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.

Introduction: COVID-19 infects minority groups with comorbidities at higher rates than whites. In addition, children are at risk of vaccine hesitancy based on parents' acceptance and due to disparity. About twenty percent of workers would get vaccinated, especially if required by work.

View Article and Find Full Text PDF

The precise determination of viral titers in virological studies is a critical step to assess the infectious viral concentration of a sample. Although conventional titration methods, such as endpoint dilution or plaque forming units are the gold standards, their widespread use for screening experiments remains limited due to the time-consuming aspect and resource-intensive requirements. This study introduces a rapid and user-friendly high-throughput screening assay for evaluating viral titers.

View Article and Find Full Text PDF

Plasma samples obtained approximately 3 ( = 100) and 12 months ( = 78) after acute SARS-CoV-2 infection were tested for S1, spike, and N antigens. There were no significant differences in plasma proteins or single-cell protein expression levels on immune cells between those with and without plasma antigen detected.

View Article and Find Full Text PDF

BackgroundRAY1216 is an alpha-ketoamide-based peptide inhibitor of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) major protease (M). This study evaluated the absorption, distribution, metabolism and excretion of [C]-labelled RAY1216 by oral administration.Research design and methodsThis phase Ι study was designed to assess the pharmacokinetics, mass balance and metabolic pathways in 6 healthy Chinese adult men after a single fasting oral administration of 240 mL (containing 400 mg/100 μCi) [C] RAY1216.

View Article and Find Full Text PDF

Objectives: Mentalization-based treatment (MBT) has promising transdiagnostic applications. The evidence base for its application in non-specialist settings, including general adult community mental health services requires further evaluation. This study explores the implementation of an MBT introductory (MBTi) group in an Irish secondary mental health service.

View Article and Find Full Text PDF